LIPOCINE INC. Operating Lease, Expense
LIPOCINE INC. (LPCN) reported Operating Lease, Expense of $376.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-03-10
- LIPOCINE INC. operating lease, expense for the quarter ending 2021-12-31 was $82.00K, a 0.00% change year-over-year.
- LIPOCINE INC. operating lease, expense for the quarter ending 2021-09-30 was $83.00K, a 0.00% change year-over-year.
- LIPOCINE INC. operating lease, expense for the quarter ending 2021-06-30 was $83.00K, a 0.00% change year-over-year.
- LIPOCINE INC. operating lease, expense for the quarter ending 2021-03-31 was $83.00K, a 0.00% change year-over-year.
- LIPOCINE INC. operating lease, expense for fiscal 2025 was $376.00K, a 2.73% increase from fiscal 2024.
- LIPOCINE INC. operating lease, expense for fiscal 2024 was $366.00K, a 3.10% increase from fiscal 2023.
- LIPOCINE INC. operating lease, expense for fiscal 2023 was $355.00K, a 4.11% increase from fiscal 2022.
- LIPOCINE INC. operating lease, expense for fiscal 2022 was $341.00K, a 3.33% increase from fiscal 2021.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | $376.00K 10-K · filed 2026-03-10 | |||
| 2024-12-31 | $366.00K 10-K · filed 2026-03-10 | |||
| 2023-12-31 | $355.00K 10-K · filed 2025-03-13 | |||
| 2022-12-31 | $341.00K 10-K · filed 2024-03-07 | |||
| 2021-12-31 | $82.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $165.00K derived: sum of 2 quarters · filed 2023-03-10 | $248.00K derived: sum of 3 quarters · filed 2023-03-10 | $330.00K 10-K · filed 2023-03-10 |
| 2021-09-30 | $83.00K 10-Q · filed 2021-11-10 | $166.00K derived: sum of 2 quarters · filed 2021-11-10 | $248.00K 10-Q · filed 2021-11-10 | $331.00K derived: sum of 4 quarters · filed 2022-03-09 |
| 2021-06-30 | $83.00K 10-Q · filed 2021-08-05 | $165.00K 10-Q · filed 2021-08-05 | $248.00K derived: sum of 3 quarters · filed 2022-03-09 | $331.00K derived: sum of 4 quarters · filed 2022-03-09 |
| 2021-03-31 | $83.00K 10-Q · filed 2021-05-06 | $165.00K derived: sum of 2 quarters · filed 2022-03-09 | $248.00K derived: sum of 3 quarters · filed 2022-03-09 | $331.00K derived: sum of 4 quarters · filed 2022-03-09 |
| 2020-12-31 | $82.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $165.00K derived: sum of 2 quarters · filed 2022-03-09 | $248.00K derived: sum of 3 quarters · filed 2022-03-09 | $330.00K 10-K · filed 2022-03-09 |
| 2020-09-30 | $83.00K 10-Q · filed 2021-11-10 | $166.00K derived: sum of 2 quarters · filed 2021-11-10 | $248.00K 10-Q · filed 2021-11-10 | $332.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $83.00K 10-Q · filed 2021-08-05 | $165.00K 10-Q · filed 2021-08-05 | $249.00K derived: sum of 3 quarters · filed 2021-08-05 | $332.00K derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $83.00K 10-Q · filed 2021-05-06 | $166.00K derived: sum of 2 quarters · filed 2021-05-06 | $249.00K derived: sum of 3 quarters · filed 2021-05-06 | $332.00K derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $83.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $166.00K derived: sum of 2 quarters · filed 2021-03-11 | $249.00K derived: sum of 3 quarters · filed 2021-03-11 | $329.00K 10-K · filed 2021-03-11 |
| 2019-09-30 | $83.00K 10-Q · filed 2020-11-10 | $166.00K derived: sum of 2 quarters · filed 2020-11-10 | $246.00K 10-Q · filed 2020-11-10 | $327.00K derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | $83.00K 10-Q · filed 2020-08-06 | $164.00K 10-Q · filed 2020-08-06 | $244.00K derived: sum of 3 quarters · filed 2020-08-06 | $324.00K derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $81.00K 10-Q · filed 2020-05-07 | $161.00K derived: sum of 2 quarters · filed 2020-05-07 | $241.00K derived: sum of 3 quarters · filed 2020-05-07 | |
| 2018-12-31 | $80.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $160.00K derived: sum of 2 quarters · filed 2020-03-13 | $323.00K 10-K · filed 2020-03-13 | |
| 2018-09-30 | $80.00K 10-Q · filed 2019-11-12 | $243.00K 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |